Our NMR findings in the CSF of severe SMA patients highlighted an influence of SMN deficiency on perturbing central ArAAs and BCAAs availability, which is consistent with the metabolomic results observed in the brain of late-symptomatic SMNΔ7 mice (Fig. 3e–g). The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.